Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ulmer

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2019
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in MiceMarcelo M Samsa, Lesley C Dupuy, Clayton W Beard, et al.
Infection and Immunity|April 7, 1998
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infectionO Denis, A Tanghe, K Palfliet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Increased DNA vaccine delivery and immunogenicity by electroporation in vivoG Widera, M Austin, D Rabussay, et al.
Gene Therapy|February 27, 2001
Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cellsK S Denis-Mize, M Dupuis, M L MacKichan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxinJ J Donnelly, J B Ulmer, L A Hawe, et al.
Journal of Virology|February 28, 2002
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virusIndresh K Srivastava, Leonidas Stamatatos, Harold Legg, et al.
Journal of Virology|June 17, 1998
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNAJ B Ulmer, T M Fu, R R Deck, et al.
Infection and Immunity|May 29, 1998
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosisS L Baldwin, C D'Souza, A D Roberts, et al.
Plos One|October 25, 2007
Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigensWalter R Weiss, Anita Kumar, George Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in miceM Dupuis, K Denis-Mize, C Woo, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2019
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in MiceMarcelo M Samsa, Lesley C Dupuy, Clayton W Beard, et al.
Infection and Immunity|April 7, 1998
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infectionO Denis, A Tanghe, K Palfliet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Increased DNA vaccine delivery and immunogenicity by electroporation in vivoG Widera, M Austin, D Rabussay, et al.
Gene Therapy|February 27, 2001
Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cellsK S Denis-Mize, M Dupuis, M L MacKichan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxinJ J Donnelly, J B Ulmer, L A Hawe, et al.
Journal of Virology|February 28, 2002
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virusIndresh K Srivastava, Leonidas Stamatatos, Harold Legg, et al.
Journal of Virology|June 17, 1998
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNAJ B Ulmer, T M Fu, R R Deck, et al.
Infection and Immunity|May 29, 1998
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosisS L Baldwin, C D'Souza, A D Roberts, et al.
Plos One|October 25, 2007
Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigensWalter R Weiss, Anita Kumar, George Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in miceM Dupuis, K Denis-Mize, C Woo, et al.
Pageof 18